Search NASA⌕ Search

SEARCH · Search NASA

Results for “e-nose”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

16 records
All sourcesNASA NTRSDOE OSTI
NASA NTRS2001

Detection of hydrazine (H) and (MMH) using cyranose E-nose

The Cyranose electronic nose (e-nose) has been used for the first time to detect hydrazine (H) and monomethyl hydrazine (MMH). The concentrations of hydrazine chosen in this study were 52 ppm (parts per million), 18 ppm, and 1.1 ppm and the concentrations of MMH was 14 ppm and 1 ppm. The Cyranose E-nose has detected hydrazine of 52 ppm and 18 ppm with a good response. The response of the E-Nose for 1.1 ppm hydrazine was insignificant. The response of E-Nose for 14 ppm MMH was significant and 1 ppm MMH was reasonably identifiable. The Cyranose E-Nose may be used to detect hydrazine and MMH with concentrations of at least 18 ppm and 1 ppm, respectively.

cyranose↗
NASA NTRS2005

E-Nose Vapor Identification Based on Dempster-Shafer Fusion of Multiple Classifiers

Electronic nose (e-nose) vapor identification is an efficient approach to monitor air contaminants in space stations and shuttles in order to ensure the health and safety of astronauts. Data preprocessing (measurement denoising and feature extraction) and pattern classification are important components of an e-nose system. In this paper, a wavelet-based denoising method is applied to filter the noisy sensor measurements. Transient-state features are then extracted from the denoised sensor measurements, and are used to train multiple classifiers such as multi-layer perceptions (MLP), support vector machines (SVM), k nearest neighbor (KNN), and Parzen classifier. The Dempster-Shafer (DS) technique is used at the end to fuse the results of the multiple classifiers to get the final classification. Experimental analysis based on real vapor data shows that the wavelet denoising method can remove both random noise and outliers successfully, and the classification rate can be improved by using classifier fusion.

Li, Winston↗
NASA NTRS2019

Noninvasive Breath Analysis Using NASA E-Nose Technology for Health Assessment

Clinical breath analysis is based on the fact that many important metabolites and biomarker molecules are present at detectable levels in exhaled breath, and many of these molecules correlate with human disease or correlate with physiological states that could lead to a decline in health. Presented is a technology that utilizes an array of chemical sensors combined with humidity, temperature and pressure for real time breath analysis to correlate the chemical information in the breath with the state and functioning of different human organs. For example, a marker for pulmonary inflammation processes of the lower respiratory tract, e.g. asthma, is the increase of the nitrogen oxide (NO) concentration in breath. Other volatile biomarkers may correlate with infectious process, metabolic conditions and inflammatory diseases, such as traumatic brain injury (TBI). This technology is also called "electronic nose" (E-Nose) in the sense that the device can mimic human nose to smell odors using a pattern recognition technique to analyze the sensor array data. Breath sampling is non-invasive and can be analyzed in real-time.

Li, Jing↗
NASA NTRS2003

Electronic nose for space program applications

The ability to monitor air contaminants in the shuttle and the International Space Station is important to ensure the health and safety of astronauts, and equipment integrity. Three specific space applications have been identified that would benefit from a chemical monitor: (a) organic contaminants in space cabin air; (b) hypergolic propellant contaminants in the shuttle airlock; (c) pre-combustion signature vapors from electrical fires. NASA at Kennedy Space Center (KSC) is assessing several commercial and developing electronic noses (E-noses) for these applications. A short series of tests identified those E-noses that exhibited sufficient sensitivity to the vapors of interest. Only two E-noses exhibited sufficient sensitivity for hypergolic fuels at the required levels, while several commercial E-noses showed sufficient sensitivity of common organic vapors. These E-noses were subjected to further tests to assess their ability to identify vapors. Development and testing of E-nose models using vendor supplied software packages correctly identified vapors with an accuracy of 70-90%. In-house software improvements increased the identification rates between 90 and 100%. Further software enhancements are under development. Details on the experimental setup, test protocols, and results on E-nose performance are presented in this paper along with special emphasis on specific software enhancements. c2003 Elsevier Science B.V. All rights reserved.

Air Pollution, Indoor/analysis↗
NASA NTRS2023

Electronic Nose Development and Preliminary Human Breath Testing for Rapid, Non-Invasive COVID-19 Detection

We adapted an existing, spaceflight-proven, robust “electronic nose” (E-Nose) that uses an array of electrical resistivity-based nanosensors mimicking aspects of mammalian olfaction to conduct on-site, rapid screening for COVID-19 infection by measuring the pattern of sensor responses to volatile organic compounds (VOCs) in exhaled human breath. We built and tested multiple copies of a hand-held prototype E-Nose sensor system, composed of 64 chemically sensitive nanomaterial sensing elements tailored to COVID-19 VOC detection; data acquisition electronics; a smart tablet with software (App) for sensor control, data acquisition and display; and a sampling fixture to capture exhaled breath samples and deliver them to the sensor array inside the E-Nose. The sensing elements detect the combination of VOCs typical in breath at parts-per-billion (ppb) levels, with repeatability of 0.02% and reproducibility of 1.2%; the measurement electronics in the E-Nose provide measurement accuracy and signal-to-noise ratios comparable to benchtop instrumentation. Preliminary clinical testing at Stanford Medicine with 63 participants, their COVID-19-positive or COVID-19-negative status determined by concomitant RT-PCR, discriminated between these two categories of human breath with a 79% correct identification rate using “leave-one-out” training-and-analysis methods. Analyzing the E-Nose response in conjunction with body temperature and other non-invasive symptom screening using advanced machine learning methods, with a much larger database of responses from a wider swath of the population, is expected to provide more accurate on-the-spot answers. Additional clinical testing, design refinement, and a mass manufacturing approach are the main steps toward deploying this technology to rapidly screen for active infection in clinics and hospitals, public and commercial venues, or at home.

COVID-19↗
NASA NTRS2003

An Evaluation of Electronic Nose for Space Program Applications

The ability to monitor air contaminants in the Shuttle and the International Space Station is important to ensure the health and safety of astronauts. Three specific space applications have been identified that would benefit from a chemical monitor: organic contaminants in crew cabins, propellant contaminants in the airlock, and pre-combustion fire detection. NASA has assessed several commercial and developing electronic noses (e-noses) for these applications. A preliminary series of tests identified those e-noses that exhibited sufficient sensitivity to the vapors of interest. These e-noses were further tested to assess their ability to identify vapors, and in-house software has been developed to enhance identification. This paper describes the tests, the classification ability of selected e-noses, and the software improvements made to meet the requirements for these space program applications.

Young, Rebecca C.↗
NASA NTRS2019

Development of a Point of Care Technology for Military Medical Applications in Austere Environments

NASA, Lawrence Livermore National Laboratory (LLNL) and the Department of Defense (DoD) share a common interest in compact medical diagnostic technologies—also known as “point of care testing” (POCT) technologies. For NASA, the need is to take care of astronauts on deep space missions. For LLNL, the focus is on technologies needed to support homeland security applications. For DoD, the need is to support warfighters in military theaters of operation, especially for prolonged field care and en route care. A recently patented technology, “Portable Medical Diagnosis Instrument” (U.S. Patent 9824870), co-invented by NASA and LLNL, is being developed further in a partnership between NASA, LLNL and Travis Air Force Base, with a focus on military applications. This instrument, the NASA-LLNL Medical Tricorder, can be used for a wide range of clinical samples including breath, saliva and blood. One component of the Tricorder is the NASA E-Nose, a carbon nanotube-based chemical sensor, integrated into a hand-held smart phone, that can detect and measure “breath biomarkers” in the gas phase of exhaled breath. The response of the NASA E-Nose is rapid, which makes it possible to detect various gas-phase substances in real time. The NASA E-Nose, with modification, can also be used for breath condensate analysis. Another component of the Tricorder is a miniaturized microfluidic analyzer, under development by LLNL, that does not require any pumps. The microfluidic analyzer can detect and measure biomarkers in liquid samples, such as blood, saliva and breath condensate. This microfluidic system requires small quantities of liquid sample and can perform analysis very rapidly (seconds to minutes), which makes it possible to detect relevant biomarkers in near real time in the field. The Clinical Investigation Facility (CIF) at Travis Air Force Base is currently conducting research with the goal to develop improved field-able technologies and procedures for the emergency response to life threatening injuries soldiers may receive in theater. This work includes experimental large animal systems and comprehensive collection of clinical specimens and physiological data. NASA and LLNL are partnering with Travis to test and further develop the Tricorder technology for high priority military applications, initially focused on lung injury models and traumatic brain injury.

Loftus, David J.↗
NASA NTRS2005

A Portable Electronic Nose For Toxic Vapor Detection, Identification, and Quantification

A new prototype instrument based on electronic nose (e-nose) technology has demonstrated the ability to identify and quantify many vapors of interest to the Space Program at their minimum required concentrations for both single vapors and two-component vapor mixtures, and may easily be adapted to detect many other toxic vapors. To do this, it was necessary to develop algorithms to classify unknown vapors, recognize when a vapor is not any of the vapors of interest, and estimate the concentrations of the contaminants. This paper describes the design of the portable e-nose instrument, test equipment setup, test protocols, pattern recognition algorithms, concentration estimation methods, and laboratory test results.

Linnell, B. R.↗
NASA NTRS2005

A Portable Electronic Nose for Toxic Vapor Detection, Identification, and Quantification

The Space Program and military use large quantities of hydrazine and monomethyl hydrazine as rocket propellant, which are very toxic and suspected human carcinogens. Current off-the-shelf portable instruments require 10 to 20 minutes of exposure to detect these compounds at the minimum required concentrations and are prone to false positives, making them unacceptable for many operations. In addition, post-mission analyses of grab bag air samples from the Shuttle have confirmed the occasional presence of on-board volatile organic contaminants, which also need to be monitored to ensure crew safety. A new prototype instrument based on electronic nose (e-nose) technology has demonstrated the ability to qualify (identify) and quantify many of these vapors at their minimum required concentrations, and may easily be adapted to detect many other toxic vapors. To do this, it was necessary to develop algorithms to classify unknown vapors, recognize when a vapor is not any of the vapors of interest, and estimate the concentrations of the contaminants. This paper describes the design of the portable e-nose instrument, test equipment setup, test protocols, pattern recognition algorithms, concentration estimation methods, and laboratory test results.

Linnell, B. R.↗
NASA NTRS2002

Electronic nose for space program applications

NASA at the Kennedy Space Center is currently assessing the ability of several commercially available and developing E-nose technologies to meet specific requirements for applications in the space program.

e-nose↗
NASA NTRS2004

A Portable Electronic Nose For Hydrazine and Monomethyl Hydrazine Detection

The Space Program and military use large quantities Hydrazine (Hz) and monomethyl hydrazine (MMI-I) as rocket propellant. These substances are very toxic and are suspected human carcinogens. The American Conference of Governmental Industrial Hygienist set the threshold limit value to be 10 parts per billion (ppb). Current off-the-shelf portable instruments require 10 to 20 minutes of exposure to detect 10 ppb concentration. This shortcofriing is not acceptable for many operations. A new prototype instrument using a gas sensor array and pattern recognition software technology (i.e., an electronic nose) has demonstrated the ability to identify either Hz or MM}{ and quantify their concentrations at 10 parts per billion in 90 seconds. This paper describes the design of the portable electronic nose (e-nose) instrument, test equipment setup, test protocol, pattern recognition algorithm, concentration estimation method, and laboratory test results.

Young, Rebecca C.↗
NASA NTRSDate not supplied

Strategies for Determining Safety of Fermented Foods Produced in Space

The BioNutrients experiments examine the feasibility of using microbially produced foods – yogurt, kefir, fermented food products– to supplement the current prepackaged food system to provide freshly synthesized nutrients and genetically engineered protein therapeutics to support crew health for sustainable and long duration crewed exploration. Safety of the products must be established as direct consumption of such products is a risk due to potential contamination with pathogenic organisms. Identifying pathogen contamination is particularly challenging as the fermenting cultures can mask the presence of contaminating organisms. Here we consider current methods of detecting coliforms, aerobic colonies, non-lactic acid bacteria, molds (yeasts), and specific pathogens including Staphylococcus aureus and salmonella. We also consider alternate and additional testing including sequencing and quantitative PCR. We investigate the use of the E-Nose developed by NASA Ames Research Center. This portable device senses volatile organic compounds in real time and can be trained to recognize “good” uncontaminated products from contaminated ones as a means of predicting food safety. Finally, we consider methods of in-flight pasteurization to increase safety and decrease overall microbial load of these products. This presentation will summarize testing status and outline the strategy that will be employed in the BioNutrients-3 ISS fermented foods experiment.

Natalie Ball↗
NASA NTRSDate not supplied

Strategies for Determining Safety of Fermented Foods Produced in Space

The BioNutrients experiments examine the feasibility of using microbially produced foods – yogurt, kefir, fermented food products– to supplement the current prepackaged food system to provide freshly synthesized nutrients and genetically engineered protein therapeutics to support crew health for sustainable and long duration crewed exploration. Safety of the products must be established as direct consumption of such products is a risk due to potential contamination with pathogenic organisms. Identifying pathogen contamination is particularly challenging as the fermenting cultures can mask the presence of contaminating organisms. Here we consider current methods of detecting coliforms, aerobic colonies, non-lactic acid bacteria, molds (yeasts), and specific pathogens including Staphylococcus aureus and salmonella. We also consider alternate and additional testing including sequencing and quantitative PCR. We investigate the use of the E-Nose developed by NASA Ames Research Center. This portable device senses volatile organic compounds in real time and can be trained to recognize “good” uncontaminated products from contaminated ones as a means of predicting food safety. Finally, we consider methods of in-flight pasteurization to increase safety and decrease overall microbial load of these products. This presentation will summarize testing status and outline the strategy that will be employed in the BioNutrients-3 ISS fermented foods experiment.

Food↗
NASA NTRSDate not supplied

BioNutrients-3: Precision Fermentation, Pasteurization, and Pathogen Detection - Towards Safe Fermentation and Production of Nutrients in Space

The BioNutrients (BN) project is developing a microbial manufacturing approach to supplement the NASA food system to address known nutrient degradation associated with long-term storage. BN uses synthetic biology to deliver high-value nutrients and therapeutics through genetic engineering of microbes and production of fermented food products like yogurt and kefir, in a fully dehydrated system. On-demand production of nutrients for human consumption requires rigorous safety protocols to ensure contaminants are not introduced during the fermentation process. The third iteration of the BN flight project, BN-3, further develops the BN project by investigating strategies for pathogen detection and pasteurization in microgravity. BN-3 will test the limits of pathogen detection using whole genome sequencing, standard microbial assays and the NASA Ames E-Nose, a volatile carbon nano tube-based sensor array, to detect unwanted microbes. BN-3 also expands on the number of nutrients produced in a single bioreactor to enhance efficiency of the system by combining production of B vitamins in conjunction with the carotenoids, beta-carotene and zeaxanthin. Serial production of food products through yogurt passaging, new updates to the fluorinated ethylene propylene bags to allow crew access via a straw, as well as use of a food safe pH indicator dye to indicate readiness of the food product, will further enhance the useability of this system. This presentation will provide status of the BN-3 flight project with the aim of advancing in-space biomanufacturing for on-demand microbially based food production for future space exploration.

Biomanufacturing↗